Tech Company Inital Public Offerings
RenovoRx IPO
RenovoRx was acquired by . The company's stock became public on 8/26/2021.
Transaction Overview
Company Name
Announced On
8/26/2021
Transaction Type
IPO
Amount
$16,650,000
Proceeds Purpose
Use of proceeds for the RenovoRx IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
4546 El Camino Real 223
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Website
Email Address
Not Recorded
Overview
RenovoRx is a medical device startup headquartered in Silicon Valley, California. We develop solutions for targeted delivery of fluids, including radiopaque media and therapeutic agents, to pancreas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shaun Bagai
Chief Medical Officer
Ramtin Agah
Founder
Kamran Najmabadi
Browse more venture capital transactions:
Prev: 8/26/2021: LevelTen Energy venture capital transaction
Next: 8/26/2021: Bodo.ai venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs